CFM
ANGO icon

Catalyst Funds Management’s AngioDynamics ANGO Stock Holding History

Catalyst Funds Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,166
Closed -$48K – 359
2024
Q3 		$48K Hold
6,166
– – 0.01% 815
2024
Q2 		$37.3K Sell
6,166
-9,400
-60% -$58K 0.01% 494
2024
Q1 		$91.4K Buy
+15,566
New +$92.5K 0.03% 414

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Catalyst Funds Management's ANGO Position: Q4 2024 in Review

Catalyst Funds Management sold out of AngioDynamics (ANGO) in Q4 2024, closing a stake of 6,166 shares — an estimated $48K sold.

Catalyst Funds Management first reported a position in ANGO in Q1 2024 and held it in 3 quarters. The position peaked at $91.4K in Q1 2024. 135 funds tracked by Wall St. Rank hold ANGO as of Q4 2024.

  • Catalyst Funds Management reported no remaining AngioDynamics position as of Q4 2024 after selling out during the quarter.
  • Catalyst Funds Management sold 6,166 AngioDynamics shares in Q4 2024, an estimated $48K.
  • Catalyst Funds Management first reported a position in AngioDynamics in Q1 2024 and held it in 3 quarters.
  • Catalyst Funds Management's AngioDynamics position peaked at $91.4K in Q1 2024.
  • 135 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2024.

Based on Catalyst Funds Management's 13F filing for Q4 2024, filed 10 Feb 2025.